AnaptysBio
ANAB
$26.34
Share price
1.23%
Change (1 day)
24.42%
Change (1 year)
Categories
AnaptysBio (ANAB) - Total debt
Total debt on the balance sheet as of December 2023 : $17.81 M
According to AnaptysBio's latest financial reports the company's total debt is $17.81 M. A company’s total debt is the sum of all current and non-current debts.
AnaptysBio - Total debt on balance sheet (from 2014 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $17.81 M | -8.41% |
| 2022-12-31 | $19.45 M | -7.18% |
| 2021-12-31 | $20.95 M | 6027.19% |
| 2020-12-31 | $0.34 M | -88.21% |
| 2019-12-31 | $2.9 M | -62% |
| 2018-12-31 | $7.63 M | -47.17% |
| 2017-12-31 | $14.44 M | 4.6% |
| 2016-12-31 | $13.81 M | 180.46% |
| 2015-12-31 | $4.92 M | 0.04% |
| 2014-12-31 | $4.92 M | 428.11% |
| 2013-12-31 | $0.93 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.75 M | -84.55% | 🇺🇸 USA |